Co-Diagnostics, Inc. to Present at ACTC Liquid Biopsy Conference in Kalamata, Greece

Rhea-AI Summary

Co-Diagnostics, Inc. (Nasdaq-CM: CODX) will present at the 5th Advances in Circulating Tumor Cells (ACTC) conference in Kalamata, Greece, from September 22-25, 2021. The presentation is scheduled for September 23 at 14:50 local time. The Company's Logix Smart™ COVID-19 Tests will be used for on-site testing of attendees, highlighting its expanding presence in Europe. Co-Diagnostics aims to engage with both new and existing customers to showcase its diagnostic products. Interested European distributors and laboratories can contact the Company for more information.

SALT LAKE CITY, Sept. 21, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that Company representatives will be presenting at the 5^th Advances in Circulating Tumor Cells (ACTC) conference in Kalamata, Greece, held on September 22-25, 2021.

Co-Diagnostics' Logix Smart™ COVID-19 Tests have also been selected to be used for on-site testing for conference attendees, following recent and ongoing efforts to strengthen the Company's presence and distribution reach across the continent.

In addition to the presentation, which will be conducted at 14:50 local time on Thursday, September 23^rd, Co-Diagnostics representatives expect to meet with new and existing customers and showcase the products available for sale in the region. European distributors or laboratories interested in learning more about these products may contact the Company at info@codiagnostics.com.

About Co-Diagnostics, Inc.:
Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets a state-of-the-art diagnostics technology. The Company's technology is utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers.

View original content to download multimedia:https://www.prnewswire.com/news-releases/co-diagnostics-inc-to-present-at-actc-liquid-biopsy-conference-in-kalamata-greece-301381915.html

SOURCE Co-Diagnostics

FAQ

What conference will Co-Diagnostics present at in September 2021?

Co-Diagnostics will present at the 5th Advances in Circulating Tumor Cells (ACTC) conference in Kalamata, Greece.

When is Co-Diagnostics' presentation scheduled at the ACTC conference?

Co-Diagnostics' presentation is scheduled for September 23, 2021, at 14:50 local time.

What product will Co-Diagnostics use for testing at the conference?

Co-Diagnostics will use its Logix Smart™ COVID-19 Tests for on-site testing of conference attendees.

What is the purpose of Co-Diagnostics' participation in the ACTC conference?

The Company aims to strengthen its presence in Europe, engage new and existing customers, and showcase its diagnostic products.

How can European distributors contact Co-Diagnostics for product inquiries?

European distributors can contact Co-Diagnostics at info@codiagnostics.com for product inquiries.